# The Effect of Donepezil on Glycemic Control in Type II Diabetics

> **NCT04507438** · PHASE2 · TERMINATED · sponsor: **University of Maryland, Baltimore** · enrollment: 7 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Donepezil 5-10 Mg Oral Tablet
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT04507438
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-12
- **Primary completion:** 2023-09-12
- **Final completion:** 2023-09-12
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2023-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04507438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04507438, "The Effect of Donepezil on Glycemic Control in Type II Diabetics". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04507438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*